Compass Therapeutics, Inc. CMPX
- tovecimig — Biliary Tract Cancer Phase 2
- tovecimig — Colorectal Cancer Phase 2
- tovecimig — Glioblastoma Phase 1
DLL4 (1 companies · 3 programs)
Companies with an active program directed at DLL4.
Companies with an active program directed at DLL4.